Malignant Pleural Mesothelioma Archive - Seite 2 von 4 - IOZK

Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy

2018-07-30/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2018-07-30 / Oncoimmunology 2018;7(12):e1474318

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human

2017-12-12/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2017-12-12 / Clin. Cancer Res. 2018 Feb;24(4):766-776

Oncolytic Viral Therapy for Mesothelioma

2017-08-24/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2017-08-24 / Front Oncol 2017;7:179

Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma

2016-05-01/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2016-05-01 / Am. J. Respir. Crit. Care Med. 2016 05;193(9):1023-31

Immunotherapy prospects in the treatment of lung cancer and mesothelioma

2014-02-01/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45

Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma

2013-10-24/in Dendritic Cells, Exosome, International Publications, Malignant Pleural Mesothelioma /von 2013-10-24 / J Extracell Vesicles 2013;2

A seven-year disease-free survivor of malignant pleural mesothelioma treated with hyperthermia and chemotherapy: a case report

2012-12-28/in Hyperthermia, International Publications, Malignant Pleural Mesothelioma /von 2012-12-28 / J Med Case Rep 2012 Dec;6:427

Dendritic cell-based immunotherapy in mesothelioma

2012-10-01/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-10-01 / Immunotherapy 2012 Oct;4(10):1011-22

Immunotherapies for non-small-cell lung cancer and mesothelioma

2012-06-28/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-06-28 / Lancet Oncol. 2012 Jul;13(7):e301-10

Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma

2010-09-21/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2010-09-21 / Mol. Cancer Ther. 2010 Oct;9(10):2761-9